内幕信息知情人管理制度
Search documents
赛隆药业集团股份有限公司第四届董事会第二十一次会议决议公告
Shang Hai Zheng Quan Bao· 2026-02-03 19:17
Group 1 - The company held its 21st meeting of the fourth board of directors on February 3, 2026, with all 9 directors present, and the meeting was conducted in accordance with legal and regulatory requirements [2][4]. - The board approved the revision of the "Insider Information Management System" [3]. - The board also approved the establishment of the "Director and Senior Management Compensation Management System," which will require further approval from the shareholders' meeting [5][7]. Group 2 - The board reviewed and confirmed the compensation for directors and senior management for 2025 and proposed a compensation plan for 2026, which will be submitted to the shareholders' meeting for approval [8][13]. - The compensation plan for 2026 includes a fixed salary and performance-based pay for directors and senior management, with performance pay constituting at least 50% of the total compensation [14][17]. - Independent directors will receive an annual allowance of 180,000 yuan, while non-independent directors' salaries will be based on their roles and responsibilities [16][17].